Evofem Biosciences (NASDAQ:EVFM) reported quarterly sales of $4.30 million which beat the analyst consensus estimate of $4.15 million by 3.61 percent. This is a 289.14 percent increase over sales of $1.10 million the same period last year.
Bitcoin, Ethereum, Dogecoin Spike: Analyst Warns Apex Crypto Could Dip Back To $20K If Tech Selloff Intensifies
Major coins traded in the green on Wednesday, as the global market cap rose 4.10% to $1.06 trillion, recorded at 8:30 p.m. EST.
